Screener
Bausch Health Companies BHC Acquisition-related contingent consideration
Acquisition-related contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept bhc:BusinessCombinationContingentConsiderationNoncurrentLiability.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Financial leases | 11 | 11 |
| Current portion of long-term debt | 889 | 225 |
| Total current liabilities | 4,530 | 4,180 |
| Acquisition-related contingent consideration | 213 | 254 |
| Non-current portion of financial leases | 20 | 23 |
| Non-current portion of long-term debt | 19,875 | 20,592 |
| Deferred tax liabilities, net | 179 | 147 |
| Other non-current liabilities | 763 | 793 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's acquisition-related contingent consideration?
- Bausch Health Companies (BHC) reported acquisition-related contingent consideration of $213M in Q1 2026.
- How has Bausch Health Companies's acquisition-related contingent consideration changed year-over-year?
- Bausch Health Companies's acquisition-related contingent consideration decreased by 24.5% year-over-year, from $282M to $213M.
- What is the long-term trend for Bausch Health Companies's acquisition-related contingent consideration?
- Over 5 years (2020 to 2025), Bausch Health Companies's acquisition-related contingent consideration has grown at a 3.3% compound annual growth rate (CAGR), from $216M to $254M.
- What does acquisition-related contingent consideration mean?
- This represents the estimated fair value of future payments owed to sellers of acquired businesses, contingent upon the achievement of specific performance milestones or financial targets. It serves as a measure of potential future cash outflows tied to the success of past M&A activities. Investors use this to evaluate the long-term financial risk and integration costs associated with inorganic growth strategies.
Ask your AI about Bausch Health Companies's acquisition-related contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude